Colorado Cannabis Sales

Once the template for legal cannabis in the United States, Colorado has seen sales shrink more than 13% over two years, placing it among the weakest performers in a peer group of mature Western markets. Its dispensary count has thinned to 662, down nearly 3% year-over-year, as sustained price declines approaching 10% force consolidation. Neighboring markets in Missouri and Oklahoma continue to pull consumer and tourist dollars that once flowed into Colorado.

24-Month Trend

State	Sales	YoY
Ohio	$110-120M	30.5%
Arizona	$100-110M	2.4%
Colorado	$100-110M	6.9%
New Jersey	$100-110M	12.5%
Oklahoma	$100-110M	13.5%

Benchmarking

Market ComparisonApr 2026

Once the template for legal cannabis in the United States, Colorado has seen sales shrink more than 13% over two years, placing it among the weakest performers in a peer group of mature Western markets. Its dispensary count has thinned to 662, down nearly 3% year-over-year, as sustained price declines approaching 10% force consolidation. Neighboring markets in Missouri and Oklahoma continue to pull consumer and tourist dollars that once flowed into Colorado.

24-Month Trend

State	Sales	YoY
Ohio	$110-120M	+30.5%
Arizona	$100-110M	-2.4%
Colorado	$100-110M	-6.9%
New Jersey	$100-110M	+12.5%
Oklahoma	$100-110M	-13.5%

Top performing dispensaries in Colorado.

Store	City	Est. Sales
#1 Star Buds - Aurora Southeast	Aurora	$.5M-1M
#2 Native Roots - Littleton	Denver	$.5M-1M
#3 The Green Solution - Fort Collins	Fort Collins	$.5M-1M
#4 Social Cannabis - Golden	Golden	$.5M-1M
#5 Green Valley Dispensary - Denver Tower Rd	Denver	$.5M-1M

Concentrates collapsed 40% year-over-year, the sharpest category decline in the state, while flower dropped more than 20% and lost its long-held lead—vapes now sit nearly tied at 31% share after surging 32% over the past year. Pre-rolls climbed almost 30%, making convenience-oriented formats the only growth engines in the market. Brands like Green Dot Labs that span both concentrates and vapes face a bifurcated landscape, gaining tailwinds in one segment while contending with freefall in another. Edibles slid 16%, leaving flower, edibles, and concentrates all in retreat as consumer spending migrates toward inhaled convenience formats.

Category	Sales	Avg Price	YoY
#1Flower	$25-35M	$20.16	20.1%
#2Vapes	$25-35M	$25.06	32.4%
#3Edibles	$15-20M	$13.95	16.2%
#4Pre-Rolls	$10-15M	$10.97	29.6%
#5Concentrates	$10-15M	$21.65	40.3%
#6Accessories	$1-2.5M	$6.44	12.9%
#7Topicals	$.5M-1M	$34.32	30.4%
#8Home-Grow	$250-500K	$22.05	290.5%
#9Oral	$250-500K	$18.5	37.3%
#10Cbd	<$250K	$25.15	42.8%